- Home
- LRMR vs ETO Comparison
LRMR vs ETO Comparison
Compare LRMR & ETO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRMR
- ETO
- Stock Information
- Founded
- LRMR N/A
- ETO 2004
- Country
- LRMR United States
- ETO United States
- Employees
- LRMR N/A
- ETO N/A
- Industry
- LRMR Biotechnology: Pharmaceutical Preparations
- ETO Investment Managers
- Sector
- LRMR Health Care
- ETO Finance
- Exchange
- LRMR Nasdaq
- ETO Nasdaq
- Market Cap
- LRMR 426.9M
- ETO 431.8M
- IPO Year
- LRMR N/A
- ETO N/A
- Fundamental
- Price
- LRMR $4.02
- ETO $25.95
- Analyst Decision
- LRMR Strong Buy
- ETO
- Analyst Count
- LRMR 8
- ETO 0
- Target Price
- LRMR $19.63
- ETO N/A
- AVG Volume (30 Days)
- LRMR 1.0M
- ETO 26.5K
- Earning Date
- LRMR 10-30-2024
- ETO 01-01-0001
- Dividend Yield
- LRMR N/A
- ETO 6.67%
- EPS Growth
- LRMR N/A
- ETO N/A
- EPS
- LRMR N/A
- ETO N/A
- Revenue
- LRMR N/A
- ETO N/A
- Revenue This Year
- LRMR N/A
- ETO N/A
- Revenue Next Year
- LRMR N/A
- ETO N/A
- P/E Ratio
- LRMR N/A
- ETO N/A
- Revenue Growth
- LRMR N/A
- ETO N/A
- 52 Week Low
- LRMR $3.01
- ETO $19.85
- 52 Week High
- LRMR $13.68
- ETO $25.21
- Technical
- Relative Strength Index (RSI)
- LRMR 26.41
- ETO 50.13
- Support Level
- LRMR $3.01
- ETO $26.00
- Resistance Level
- LRMR $6.91
- ETO $26.28
- Average True Range (ATR)
- LRMR 0.55
- ETO 0.17
- MACD
- LRMR -0.19
- ETO -0.02
- Stochastic Oscillator
- LRMR 31.28
- ETO 34.25
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About ETO Eaton Vance Tax-Advantage Global Dividend Opp
Eaton Vance Tax-advtgd Global Divid Oppo is a diversified, closed-end management investment company. Its investment objective is to provide a high level of after-tax total return consisting of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. The portfolio of investments consists of capital markets, chemicals, diversified, beverages, banks, electric utilities, oil, gas and consumable fuels, personal products, and other areas.